Leaflet HAVRIX JUNIOR 720 HEPATITIS A VACCINE 720 U.EI. / 0.5ml injection suspension

Indicated for: prevention of hepatitis A

Route of administration: injectable

Substance: hepatitis A vaccine inactivated adsorbed (vaccine)

ATC: J07BC02 (Antiinfectives for systemic use | Viral vaccines | Hepatitis vaccines)

Precautions:
Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Refrigerated storage
Refrigerated storage

Store in the refrigerator as instructed in the leaflet.

Protect from light
Protect from light

Store protected from light.

The inactivated adsorbed hepatitis A vaccine is used to prevent infection with the hepatitis A virus (HAV), which can cause acute hepatitis, an inflammatory liver disease. The vaccine contains inactivated hepatitis A viruses adsorbed onto an adjuvant to stimulate a stronger immune response.

The vaccine is administered intramuscularly, usually in two doses, 6-12 months apart. It is recommended for individuals traveling to endemic areas, children, food industry workers, and others at increased risk of infection.

Common side effects include pain at the injection site, mild fever, fatigue, and nausea. In rare cases, severe allergic reactions may occur.

The inactivated adsorbed hepatitis A vaccine is an important preventive measure for reducing the risk of HAV infection and its associated complications, contributing to public health protection.

General data about HAVRIX JUNIOR 720 HEPATITIS A VACCINE 720 U.EI. / 0.5ml

  • Substance: hepatitis A vaccine inactivated adsorbed
  • Date of latest medicines list: 01-06-2026
  • Product code: W57776001
  • Concentration: 720 U.EI. / 0.5ml
  • Pharmaceutical form: injection suspension
  • Packing volume: 0,5ml
  • Product type: Original
  • Price: 77.01 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA
  • Holder: GLAXOSMITHKLINE BIOLOGICALS S.A. - BELGIA
  • Number: 3696/2011/01
  • Shelf life: 3 years

Pharmaceutical forms available for hepatitis A vaccine inactivated adsorbed

Concentrations available for hepatitis A vaccine inactivated adsorbed

  • 1440 U.El./ml
  • 160U
  • 720 U.EI./0.5ml
  • 80U/0.5ml